Product
SG001
4 clinical trials
1 drug
5 indications
Indication
Advanced Solid TumorIndication
Metastatic Colorectal CancerIndication
RecurrentIndication
Esophageal Squamous CarcinomaDrug
SG001Clinical trial
A Phase I/II Study To Evaluate The Safety, Tolerability, Pharmacokinetic Profile And Preliminary Efficacy Of Simmitinib Plus SG001 in Patients With Advanced Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2027-01-30
Clinical trial
A Randomized, Controlled, Open-label Phase Ⅱ Study of The Safety, Tolerability and Efficacy of JMT101 and Irinotecan Combined With SG001 in Patients With Metastatic Colorectal Cancer (mCRC)Status: Not yet recruiting, Estimated PCD: 2024-07-01
Clinical trial
A Randomised, Double-blind, Placebo-controlled, Multicentre Phase Ш Clinical Study to Evaluate the Efficacy and Safety of First-line Treatment With SG001 Plus Chemotherapy±Bevacizumab Versus Placebo Plus Chemotherapy±Bevacizumab for PD-L1 Positive (CPS≥1) Women With Recurrent, or Metastatic Cervical CancerStatus: Not yet recruiting, Estimated PCD: 2024-07-31
Clinical trial
A Multicenter, Open-label, Phase Ib/II Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy Versus Paclitaxel in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.Status: Not yet recruiting, Estimated PCD: 2027-04-01